Table 2.
Interventions and medication at discharge
| Clopidogrel (n = 577) | Ticagrelor (n = 426) | P value | |
|---|---|---|---|
| Interventions | |||
| Radial access | 409 (69.8) | 331 (77.7) | 0.02 |
| Severity of coronary disease | |||
| No sign. coronary disease* | 155 (26.9) | 94 (22.1) | 0.15 |
| 1 vessel disease | 169 (29.3) | 127 (29.8) | |
| 2 vessel disease | 101 (17.5) | 102 (23.9) | |
| 3 vessel disease | 112 (19.4) | 78 (18.3) | |
| Left main stenosis | 40 (6.9) | 25 (5.9) | |
| PCI ad hoc | 244 (42.2) | 200 (46.9) | 0.14 |
| PCI with stent | 194 (33.6) | 159 (37.3) | 0.05 |
| PCI with DEB | 51 (8.8) | 51 (12.0) | 0.04 |
| PCI with DES | 165 (28.6) | 155 (36.4) | <0.01 |
| PCI including rotablator | 3 (0.5) | 4 (0.9) | 0.05 |
| Diagnostic procedure (FFR, iFR) | 70 (12.1) | 64 (15.0) | 0.11 |
| CA only | 263 (45.6) | 162 (38.0) | 0.02 |
| Planned interventions | |||
| Elective PCI | 20 (3.5) | 24 (5.6) | 0.01 |
| Elective CABG | 80 (13.9) | 44 (10.3) | 0.01 |
| Revascularisation total | 344 (59.6) | 268 (62.9) | 0.29 |
| Number of stents | 0.21 | ||
| 1 stent | 139 (24.1) | 100 (23.5) | |
| 2 stents | 43 (7.5) | 46 (10.8) | |
| 3 or more stents | 12 (2.1) | 13 (3.1) | |
| Medication at discharge | |||
| Aspirin | 510 (88.4) | 377 (88.5) | 0.96 |
| Clopidogrel | 256 (44.4) | 144 (33.8) | <0.01 |
| Ticagrelor | 3 (0.5) | 46 (10.8) | <0.01 |
| Warfarin | 43 (7.5) | 40 (9.4) | 0.27 |
| NOAC | 1 (0.2) | 3 (0.7) | 0.32 |
| DAPT | 247 (42.8) | 188 (44.1) | 0.68 |
| DAT | 0 (0) | 1 (0.2) | 0.43 |
| TAT | 24 (4.2) | 16 (3.8) | 0.75 |
Results are presented as numbers and (percentages). PCI, percutaneous coronary intervention; DEB, drug eluting balloon; DES, drug eluting stent; FFR, fractional flow reserve; iFR, instantaneous wave-free ratio; CABG, coronary artery bypass grafting; NOAC, non-vitamin K antagonist oral anticoagulant; DAPT, dual antiplatelet therapy; DAT, dual antithrombotic therapy; TAT, triple antithrombotic therapy.
*
Including 4 patients with inconclusive findings (2 in each group).